Whole blood transcriptomics reveals granulocyte colony‐stimulating factor as a mediator of cardiopulmonary bypass‐induced systemic inflammatory response syndrome
Clinical & Translational Immunology · 2024-01 · 13 (2)
DOI: 10.1002/cti2.1490 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Translational Immunology, online erschienen am 19.02.2024. Verfasst von Katherine R Martin und 8 weiteren Autor:innen. Beteiligte Einrichtung: WEHI Parkville VIC Australia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: John T. Reid Charitable Trusts, Arthritis Australia, National Health and Medical Research Council.
Abstract (Originalsprache)
Objectives
Systemic inflammatory response syndrome (SIRS) is a frequent complication of cardiopulmonary bypass (CPB). SIRS is associated with significant morbidity and mortality, but its pathogenesis remains incompletely understood, and as a result, biomarkers are lacking and treatment remains expectant and supportive. This study aimed to understand the pathophysiological mechanisms driving SIRS induced by CPB and identify novel therapeutic targets that might reduce systemic inflammation and improve patient outcomes.
Methods
Twenty‐one patients undergoing cardiac surgery and CPB were recruited, and blood was sampled before, during and after surgery. SIRS was defined using the American College of Chest Physicians/Society of Critical Care Medicine criteria. We performed immune cell profiling and whole blood transcriptomics and measured individual mediators in plasma/serum to characterise SIRS induced by CPB.
Results
Nineteen patients fulfilled criteria for SIRS, with a mean duration of 2.7 days. Neutrophil numbers rose rapidly with CPB and remained elevated for at least 48 h afterwards. Transcriptional signatures associated with neutrophil activation and degranulation were enriched during CPB. We identified a network of cytokines governing these transcriptional changes, including granulocyte colony‐stimulating factor (G‐CSF), a regulator of neutrophil production and function.
Conclusions
We identified neutrophils and G‐CSF as major regulators of CPB‐induced systemic inflammation. Short‐term targeting of G‐CSF could provide a novel therapeutic strategy to limit neutrophil‐mediated inflammation and tissue damage in SIRS induced by CPB.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- WEHI Parkville VIC Australia.
- Department of Medical Biology University of Melbourne Parkville VIC Australia.
- CSL Innovation, Bio21 Institute Parkville VIC Australia.
- Cardiothoracic Surgery Royal Melbourne Hospital Parkville VIC Australia.
- Department of Surgery University of Melbourne Parkville VIC Australia.
- Department of Rheumatology Royal Melbourne Hospital Parkville VIC Australia.
ORCID-Profile: Katherine R Martin
Förderung
- John T. Reid Charitable Trusts
- Arthritis Australia
- National Health and Medical Research Council
Zitieren
APA
Martin, K. R., Gamell, C., Tai, T. Y., Bonelli, R., Hansen, J., Tatoulis, J., Alhamdoosh, M., Wilson, N., & Wicks, I. (2024). Whole blood transcriptomics reveals granulocyte colony‐stimulating factor as a mediator of cardiopulmonary bypass‐induced systemic inflammatory response syndrome. Clinical & Translational Immunology, 13(2). https://doi.org/10.1002/cti2.1490
Vancouver
Martin KR, Gamell C, Tai TY, Bonelli R, Hansen J, Tatoulis J, et al. Whole blood transcriptomics reveals granulocyte colony‐stimulating factor as a mediator of cardiopulmonary bypass‐induced systemic inflammatory response syndrome. Clinical & Translational Immunology. 2024;13(2). doi:10.1002/cti2.1490
BibTeX
@article{Martin2024,
author = {Martin, Katherine R and Gamell, Cristina and Tai, Tsin Yee and Bonelli, Roberto and Hansen, Jacinta and Tatoulis, James and Alhamdoosh, Monther and Wilson, Nicholas and Wicks, Ian},
title = {Whole blood transcriptomics reveals granulocyte colony‐stimulating factor as a mediator of cardiopulmonary bypass‐induced systemic inflammatory response syndrome},
journal = {Clinical & Translational Immunology},
year = {2024},
volume = {13},
number = {2},
doi = {10.1002/cti2.1490}
}
EUVIMED